2seventy bio Inc (TSVT)
4.785
-0.22
(-4.30%)
USD |
NASDAQ |
May 17, 16:00
4.785
0.00 (0.00%)
After-Hours: 16:40
2seventy bio Cash from Investing (Quarterly): 21.83M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 21.83M |
December 31, 2023 | 47.89M |
September 30, 2023 | 16.05M |
June 30, 2023 | -64.88M |
March 31, 2023 | 44.80M |
December 31, 2022 | -8.50M |
September 30, 2022 | -82.30M |
Date | Value |
---|---|
June 30, 2022 | 49.80M |
March 31, 2022 | 44.75M |
December 31, 2021 | 1.014M |
September 30, 2021 | -8.624M |
June 30, 2021 | -3.625M |
March 31, 2021 | -6.351M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-82.30M
Minimum
Sep 2022
49.80M
Maximum
Jun 2022
3.989M
Average
1.014M
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
Bristol-Myers Squibb Co | -19.62B |
Johnson & Johnson | -464.00M |
Macrogenics Inc | 24.79M |
Akebia Therapeutics Inc | 0.00 |
Tango Therapeutics Inc | -11.20M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -41.88M |
Cash from Financing (Quarterly) | 0.386M |
Free Cash Flow | -168.04M |
Free Cash Flow Per Share (Quarterly) | -0.816 |
Free Cash Flow to Equity (Quarterly) | -42.49M |
Free Cash Flow to Firm (Quarterly) | -42.49M |
Free Cash Flow Yield | -68.32% |